| Literature DB >> 29601526 |
Andrzej Marcinkiewicz1, Wojciech Hanke2, Paweł Kałużny3, Agnieszka Lipińska-Ojrzanowska4, Marta Wiszniewska5, Jolanta Walusiak-Skorupa6.
Abstract
Worldwide epidemiological data indicates insufficient diagnosis of diabetes as an increasing public health problem. In the search for solutions to this disadvantageous situation, occupational medicine health services seem to open up a unique opportunity to recognize some abnormalities in the early stages, especially among the asymptomatic working-age population. 316 workers underwent obligatory prophylactic examinations. In patients with twice assayed FGL ≥ 126 mg/dL (7.0 mmol/L) an additional intervention was implemented, including further diagnostic processes and therapy in General Practice (GP), followed by examination by an occupational health specialist within 3 months. The diagnosis of previously unknown diabetes was established among 2.5% of examined workers. All patients referred to the GP due to detected glycaemia impairment visited their doctor and finished the diagnostic process, took up therapy constrained by the occupational health physician to show the effects of intervention within 3 months. Prophylactic medical check-ups allow improved compliance and medical surveillance over glycaemia impairment in patients with prediabetes states, unknown diabetes or uncontrolled clinical course of diabetes. Considering fasting glucose level during mandatory prophylactic examination helps effective prevention of diabetes and its complications and thus provides public health system benefits.Entities:
Keywords: adherence; compliance; diabetes; glycaemia impairment; impaired fasting glucose; occupational health
Mesh:
Substances:
Year: 2018 PMID: 29601526 PMCID: PMC5923680 DOI: 10.3390/ijerph15040638
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Chart of the study design and intervention implemented among workers with a recognized glycaemia impairment.
Figure 2Glycaemia impairment in the study group of workers (n = 316).
Characteristics of the study participants without previous recognition of diabetes (n = 305).
| Risk Factor | Males | Females | Both |
|---|---|---|---|
| Age > 45 years | 68 (35) | 33 (29) | 101 (33) |
| BMI > 25kg/m2 | 137 (71) | 38 (34) | 175 (57) |
| Abdominal obesity: M > 94 cm of WC, F > 80 cm of WC | 116 (60) | 58 (51) | 174 (57) |
| Low daily physical activity * | 81 (42) | 57 (50) | 138 (45) |
| Improper diet ** | 82 (43) | 30 (26) | 112 (37) |
| History of arterial hypertension | 46 (24) | 14 (12) | 60 (20) |
| Family history of diabetes | 65 (34) | 51 (45) | 116 (38) |
| Positive history of glycaemia impairment | 31 (16) | 10 (9) | 41 (13) |
| Lack of glycaemia impairment control *** | 18 (9) | 4 (3) | 22 (7) |
| Lack of previous glycaemia testing | 64 (33) | 33 (29) | 97 (32) |
BMI—Body Mass Index; F—Females; M—Males; n—number of; WC—waist circumference; * Low daily physical activity—according to Findrisc form [5] lack of at least 30 min of daily physical activity; ** Improper diet—according to Findrisc form [5] diet poor in vegetables and fruit; *** Lack of following control tests despite detection of glycaemia impairment.
Risk factors for development of the impaired carbohydrate metabolism evaluated in the study group without the prior diagnosis of diabetes (n = 305).
| Risk Factor | Males ( | Females ( | ||||
|---|---|---|---|---|---|---|
| FGL at Reference Range <100 mg/dL | FGL ≥ 100 mg/dL | OR (95% CI) | FGL at Reference Range <100 mg/dL | FGL ≥ 100 mg/dL | OR (95% CI) | |
| Age > 45 years | 24 (20.3) | 44 (59.5) | 5.74 (3.01–10.95) | 26 (26.3) | 7 (50) | 2.81 (0.9–8.77) |
| BMI ≥ 25 kg/m2 | 74 (62.7) | 63 (85.1) | 3.41 (1.62–7.15) | 28 (28.3) | 10 (71.4) | 6.34 (1.84–21.89) |
| Abdominal obesity * | 55 (46.6) | 61 (82.4) | 5.37 (2.67–10.82) | 46 (46.5) | 12 (85.2) | 6.91 (1.47–32.51) |
| Low daily physical activity ** | 41 (34.47) | 40 (54.1) | 2.26 (1.25–4.09) | 46 (46.5) | 11 (78.6) | 4.22 (1.11–16.07) |
| Improper diet *** | 52 (44.1) | 30 (40.5) | 0.87 (0.48–1.56) | 27 (27.3) | 3 (21.4) | 0.73 (0.19–2.81) |
| History of AH | 16 (13.6) | 30 (40.5) | 4.35 (2.15–8.77) | 10 (10.1) | 4 (28.6) | 3.56 (0.94–13.48) |
| Family history of DM | 40 (33.9) | 25 (33.8) | 0.99 (0.54–1.84) | 43 (43.4) | 8 (57.1) | 1.74 (0.56–5.38) |
| Positive history of glycaemia impairment | 8 (7) | 23 (31) | 6.20 (2.59–14.81) | 5 (5) | 5 (36) | 10.44 (2.53–43.02) |
| Lack of glycaemia impairment control *** | 4 (3) | 14 (19) | 6.65 (2.09–21.09) | 2 (2) | 2 (14) | 8.08 (1.04–62.76) |
| Lack of previous glycaemia testing | 45 (38) | 19 (26) | 0.56 (0.29–1.06) | 31 (31) | 2 (14) | 0.36 (0.07–1.73) |
BMI—Body Mass Index. FGL—fasting glucose level. n—number of. * Abdominal obesity—Male >94 cm waist circumference, Female >80 cm waist circumference. ** Low daily physical activity—according to Findrisc form [5] lack of at least 30 min of daily physical activity. ** Improper diet—according to Findrisc form [5] diet poor in vegetables and fruit. *** Lack of following control tests despite detection of glycaemia impairment.
The risk of developing diabetes type 2 within the next 10 years in patients with detected glycaemia impairment and without a prior diagnosis of diabetes (n = 305). According to Findrisc form [5].
| 10 Years Risk of DM Type 2 Development | All | Fasting Glucose Level in Venous Blood | ||
|---|---|---|---|---|
| 70–99 mg/dL (3.9–5.5 mmol/L) | 100–125 mg/dL (5.6–6.9 mmol/L) | ≥126 mg/dL (7.0 mmol/L) | ||
| Low (<1%) | 141 (46.2) | 123 (87.2) | 18 (12.8) | 0 |
| Slightly elevated (4%) | 80 (26.2) | 60 (75) | 19 (23.8) | 1 (1.3) |
| Moderate (16.6%) | 34 (11.1) | 16 (47.1) | 15 (44.1) | 3 (8.8) |
| High (33%) | 44 (14.4) | 16 (36.4) | 26 (59.1) | 2 (4.5) |
| Very high (50%) | 6 (2.0) | 2 (33.3) | 2 (33.3) | 2 (33.3) |
DM—diabetes mellitus; Total risk score for developing type 2 diabetes within next 10 years according to Findrisc form [5]: <7 pc—low: estimated 1 in 100 persons will develop DM type 2. 7–11 pc—slightly elevated: estimated 1 in 25 persons will develop DM type 2. 12–14 pc—moderate: estimated 1 in 6 persons will develop DM type 2. 15–20 pc—high: estimated 1 in 3 persons will develop DM type 2 >20 pc—very high: estimated 1 in 2 persons will develop DM type 2.